This is the first of our Legal Issue Series, which will answer hard immigration questions and will attempt to fill in the many holes in the immigration system through legal analysis.
Overview
This is the first of our Legal Issue Series, which will answer hard immigration questions and will attempt to fill in the many holes in the immigration system through legal analysis. The first of these holes is a twist to a common factual scenario: A petitioner-company wants to petition one of its three full-time researchers for an EB-1B visa. However, the full-time researcher in question is currently on a nonimmigrant visa (L-1B, H-1B, etc.).
The EB-1B visa we’ve previously discussed, and can be found here. In the context of our situation at hand, the EB-1B visa can be used for a variety of research institutions or “medical practice/research centers” as defined in the Immigration and Nationality Act (“INA”). Some of these institutions may be small with only two or three full-time researchers. The number of full-time researchers is important for an organization petitioning for an EB-1B visa for a new full-time researcher, because the INA states that a visa is available for a researcher if:
The alien seeks to enter the United States for a comparable position to conduct researcher in the area with a department, division, or institute of a private employer, if the department, division, or institute employs at least 3 persons full-time in research activities and has achieved documented accomplishments in an academic field.
INA § 203(b)(1)(B)(iii)(III); 8 U.S.C. § 1153(b)(1)(B)(iii)(III) (emphasis added)
The focus of this article will be the bolded portion. The hard immigration question applies in the situation where the petitioner-company has three full-time researchers, but one of the three is on a temporary nonimmigrant visa (L-1, H1-B, etc.) and is now seeking to adjust their status to receive a EB-1B visa.
There is little guidance in the rest of the INA or legislative history to help answer this question. This question could make or break smaller institutions with three full-time researchers because it could potentially bar them from receiving EB-1B visas for future full-time researchers.
On one hand, one could argue that the third nonimmigrant visa researcher would help the petitioner-company qualify as having three full-time researchers. Since the petitioner-company already has three full-time researchers, their visa status should not matter and the nonimmigrant visa researcher can adjust their status to receive an EB-1B visa.
On the other hand, the argument could be made that the institution must have three full-time researchers who are not currently seeking an EB-1B visa. This is from the language of § 203(b)(1)(B)(iii)(III) as quoted above: “seeks to enter” and “employs at least 3 persons full-time” are in the present tense, and thus the petitioner-company must already have three full-time researchers. This is because the third researcher is “seeking to enter” by attempting to receive an EB-1B visa, even though the researcher is in the United States on a nonimmigrant visa. Thus, he may not count as the third anymore for purposes of the EB-1B petition.
The Administrative Appeals Office (“AAO”), a quasi-judicial branch that deals with some types of immigration appeals, addressed this issue in an unpublished decision and agreed with the second argument. Given the present tense of the statutory language and that the Director of the California Service Center used that interpretation, the AAO gave that interpretation deference, as the AAO will typically do as long as the interpretation is reasonable.
In conclusion, a petitioner-company who is attempting to obtain an EB-1B visa for a full-time researcher must have three full-time researchers who are not seeking any visas. Even though one of the three researchers has a nonimmigrant visa (L-1, H1-B, etc.) and is currently employed at the petitioner-company, a petitioner-company cannot adjust that researcher under an EB-1B visa.
DocuSign has announced its acquisition of AI-based contract lifecycle management provider Lexion for $165M, aiming to bolster its Intelligent Agreement Management platform.
Infinite Reality announces the appointment of Scott Waldbaum as its Senior Vice President, General Counsel, and Assistant Corporate Secretary, marking a significant step in its plans to go public.
Stephen Simcock, previously a lead consumer-banking lawyer at JPMorgan Chase, has been appointed General Counsel of fintech company SoFi Technologies, succeeding the retiring Rob Lavet.
Generals Counsel talk about how to prepare for AI decisions in business with the changing regulatory landscape.
The global market for AI-related products is inflating at a rapid rate of 40% to 55% annually and will hit as much as $990 billion in 2027, as the technology’s quick adoption disrupts companies and economies, a Bain & Co. report said.
A company’s mission statement is its declaration of where it wants to go – that means that all its activities should be geared towards helping it get there. As a Tuareg clansman in the Sahara reads the stars and the sand dunes to help him reach a certain oasis, a company’s spreadsheets and flowcharts should only be tools to enable it to arrive at its destination.
Eve AI has received funding of $14 million to develop a platform to automate discovery and research.
A new U.S. law requires ByteDance to divest its U.S. operations, risking a ban if the company refuses. TikTok plans to challenge the law in court.
Generals Counsel discuss how they enforce a company social media policy without infringing on personal rights.